Type to search

Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer | Pharmtech Focus
Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies | Pharmtech Focus
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer | Pharmtech Focus